|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
58
|
|
pubmed:dateCreated |
2004-7-8
|
|
pubmed:abstractText |
Chronic hepatitis C infection is a serious therapeutic problem. Interferon therapy is one of the possible methods leading to HCV infection elimination in some patients. The aim of the study was the estimation of administration of interferon alpha 2a and its effect on the lymphocyte subpopulations in peripheral blood in patients with chronic hepatitis C.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1088-92
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15239252-Adult,
pubmed-meshheading:15239252-Antigens, CD,
pubmed-meshheading:15239252-Antiviral Agents,
pubmed-meshheading:15239252-B-Lymphocyte Subsets,
pubmed-meshheading:15239252-Female,
pubmed-meshheading:15239252-HLA-DR Antigens,
pubmed-meshheading:15239252-Hepatitis C, Chronic,
pubmed-meshheading:15239252-Humans,
pubmed-meshheading:15239252-Interferon-alpha,
pubmed-meshheading:15239252-Killer Cells, Natural,
pubmed-meshheading:15239252-Lymphocyte Subsets,
pubmed-meshheading:15239252-Male,
pubmed-meshheading:15239252-Middle Aged,
pubmed-meshheading:15239252-Recombinant Proteins,
pubmed-meshheading:15239252-T-Lymphocyte Subsets
|
|
pubmed:articleTitle |
Immunological response in chronic hepatitis C virus infection during interferon alpha therapy.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Medical Academy of Bialystok, Poland. apanasiuk@wp.pl
|
|
pubmed:publicationType |
Journal Article
|
